2025-05-06 - Analysis Report
## Colgate-Palmolive Co. (CL) Stock Review

This report analyzes Colgate-Palmolive Co. (CL), a leading manufacturer of consumer products, including oral hygiene, personal care, and household cleaning items.

**1. Performance vs. S&P 500 (VOO):**

Colgate-Palmolive's cumulative return (37.81%) significantly underperformed the S&P 500's return (82.57%) over the analyzed period.  The difference is -44.8%, placing it at the 29.4th percentile of its historical range of underperformance relative to the S&P 500 (ranging from -66.7% to 7.8%). This suggests CL's underperformance is notable but not historically extreme.

**Alpha and Beta Analysis:**

The provided data shows fluctuating alpha and beta values over the years.  While alpha occasionally shows positive outperformance relative to the market (0.8 in 2019-2021), it's generally low or even negative, suggesting inconsistent outperformance against the market benchmark. The beta values remain relatively high (mostly above 0.5), indicating higher sensitivity to market fluctuations than the overall market.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 16.0% | 4.2% | -16.0% | 0.1 | 51.2 |
| 2016-2018  | -9.0% | 65.3% | -30.0% | 0.1 | 41.4 |
| 2017-2019  | 10.0% | 65.3% | -24.0% | -0.3 | 49.1 |
| 2018-2020  | 22.0% | 65.3% | -8.0% | 0.3 | 62.4 |
| 2019-2021  | 34.0% | 58.5% | -26.0% | 0.8 | 63.7 |
| 2020-2022  | 11.0% | 68.9% | 2.0% | 0.7 | 60.3 |
| 2021-2023  | 8.0% | 68.9% | -13.0% | 0.6 | 62.5 |
| 2022-2024  | 16.0% | 68.9% | -5.0% | 0.5 | 72.9 |
| 2023-2025  | 15.0% | 62.4% | -6.0% | 0.2 | 75.2 |


**2. Recent Price Movement:**

* Closing Price: $92.70
* 5-Day Moving Average: $94.52
* 20-Day Moving Average: $92.81
* 60-Day Moving Average: $90.45

The price is slightly below the 5-day and 20-day moving averages, suggesting a recent downward trend, although it's still above the longer-term 60-day average.

**3. Technical Indicators:**

* Market Risk Indicator (MRI): 0.4053 (Medium Risk)
* RSI: 43.92 (approaching oversold territory, but not definitively so)
* PPO: 0.0968 (positive, indicating upward momentum, though weak)
* Recent Relative Strength Change (20-day): -9.1% (short-term downward trend)
* Expected Return (vs. S&P 500, long-term): -88.2%  This indicates a significant predicted underperformance compared to the S&P 500 over a longer timeframe (2+ years), assuming current trends continue.


**4. Recent Earnings Analysis:**

The earnings data shows relatively stable EPS and revenue figures, with slight fluctuations. There's no clear upward or downward trend visible in the short-term data provided.

| 날짜       | EPS | 매출       |
|------------|-----|------------|
| 2025-04-25 | 0.85 | 4.91 B$    |
| 2024-10-25 | 0.9  | 5.03 B$    |
| 2024-07-26 | 0.89 | 5.06 B$    |
| 2024-04-26 | 0.83 | 5.07 B$    |
| 2025-04-25 | 0.83 | 5.07 B$    |


**5. Financial Information:**

The absence of "Total Revenue" and "Gross Profit" data prevents a comprehensive financial analysis.  Further data is needed for a complete assessment.


**6. Overall Conclusion:**

Colgate-Palmolive (CL) has significantly underperformed the S&P 500 recently. While recent earnings are relatively stable, the lack of strong upward momentum in earnings and the negative long-term expected return relative to the S&P 500 are concerning.  Technical indicators suggest a neutral-to-bearish short-term outlook.  The missing financial data limits a thorough assessment.  Further investigation into the reasons for underperformance and a more complete financial dataset are necessary for a more informed investment decision.  The high beta suggests significant market sensitivity; therefore, investors should consider their overall risk tolerance.
